International Fuels News
Thursday July 19 , 2007 9:00 AM Eastern Time
European Bio-Fuels Distributor Purchases IFT’s DiesoLIFT™ EM-1
ST. LOUIS, July 19, 2007 – International Fuel Technology, Inc. (IFT) (OTCBB: IFUE) today announced that a European bio-fuels distributor made an initial purchase order of DiesoLIFT™ EM-1. IFT expects annual DiesoLIFT™ EM-1 sales to this customer to reach 25 tons. DiesoLIFT™ EM-1, a variation of IFT’s DiesoLIFT™ 10, is a proprietary fuel additive formulation specifically designed to enhance the performance of bio-fuels and bio-fuel blends.
“This purchase order is a clear indication of the progress we are making in the bio-fuels market,” said Axel Farhi, IFT’s Director of Global Business Development. “The benefits our technology brings to the performance of bio-fuels are now recognized and accepted in the market. We expect this purchase order to be the first of many from bio-fuel manufacturers and distributors.”
The demonstrated benefits of IFT’s multi-functional fuel additive formulations in independent laboratory tests at BfB Laboratories (see IFT press release dated February 26, 2007) has generated substantial interest from bio-fuel manufacturers and distributors. The testing at BfB Laboratories demonstrated that use of IFT technology with bio-fuel blends provided significant benefits and solutions to two very critical issues associated with bio-fuel blend use: oxidation stability and deposit control.
In addition, use of IFT technology has proven to enhance combustion and improve fuel economy. This benefit is especially valuable with bio-fuel use as combustion of bio-fuels generates less energy and provides less fuel economy compared to traditional diesel fuel.
NOTE: Statements contained in this web site that are not strictly historical are forward-looking within the meaning of the safe harbor clause of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that may cause the Company’s actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the Company’s product both domestically and abroad, the Company’s ability to continue to develop its market, general economic conditions and other factors that may be more fully described in the Company’s literature and any periodic filing with the Securities and Exchange Commission.
